Predicting Response to Therapy for Autoimmune and Inflammatory Diseases Using a Folate Receptor-Targeted Near-Infrared Fluorescent Imaging Agent.
about
Nanomedicines for dysfunctional macrophage-associated diseases.In-vivo monitoring of anti-folate therapy in arthritic rats using [18F]fluoro-PEG-folate and positron emission tomography.Stimuli-responsive multifunctional glyconanoparticle platforms for targeted drug delivery and cancer cell imagingSynthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors: a patent evaluation of US20160011199A1.
P2860
Predicting Response to Therapy for Autoimmune and Inflammatory Diseases Using a Folate Receptor-Targeted Near-Infrared Fluorescent Imaging Agent.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Predicting Response to Therapy ...... red Fluorescent Imaging Agent.
@en
Predicting Response to Therapy ...... red Fluorescent Imaging Agent.
@nl
type
label
Predicting Response to Therapy ...... red Fluorescent Imaging Agent.
@en
Predicting Response to Therapy ...... red Fluorescent Imaging Agent.
@nl
prefLabel
Predicting Response to Therapy ...... red Fluorescent Imaging Agent.
@en
Predicting Response to Therapy ...... red Fluorescent Imaging Agent.
@nl
P2860
P1476
Predicting Response to Therapy ...... red Fluorescent Imaging Agent.
@en
P2093
Lindsay E Kelderhouse
Sakkarapalayam Mahalingam
P2860
P2888
P304
P356
10.1007/S11307-015-0876-Y
P577
2016-04-01T00:00:00Z